Scientific Committee on Health, Environmental and Emerging Risks
SCHEER GUIDELINES
on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
全文翻译版,参考以下链接
http://doc.trainin.cn/pagePDF?filePath=20220514134122_328.pdf&id=2892
以下为翻译预览下载
前10页预览-关于含邻苯⼆甲酸酯医疗器械涵盖致癌、致突变、致生殖毒性或内分泌干扰的受益风险评估-印.pdf
最新评论